- Home
- STG vs GNTA Comparison
STG vs GNTA Comparison
Compare STG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- GNTA
- Stock Information
- Founded
- STG 2003
- GNTA 2014
- Country
- STG China
- GNTA Italy
- Employees
- STG N/A
- GNTA N/A
- Industry
- STG Other Consumer Services
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STG Real Estate
- GNTA Health Care
- Exchange
- STG Nasdaq
- GNTA Nasdaq
- Market Cap
- STG 73.4M
- GNTA 81.2M
- IPO Year
- STG 2018
- GNTA 2021
- Fundamental
- Price
- STG $9.20
- GNTA $3.85
- Analyst Decision
- STG
- GNTA Strong Buy
- Analyst Count
- STG 0
- GNTA 1
- Target Price
- STG N/A
- GNTA $25.00
- AVG Volume (30 Days)
- STG 63.0K
- GNTA 6.3K
- Earning Date
- STG 08-14-2025
- GNTA 01-01-0001
- Dividend Yield
- STG N/A
- GNTA N/A
- EPS Growth
- STG N/A
- GNTA N/A
- EPS
- STG 3.09
- GNTA N/A
- Revenue
- STG $269,356,990.00
- GNTA N/A
- Revenue This Year
- STG N/A
- GNTA N/A
- Revenue Next Year
- STG N/A
- GNTA N/A
- P/E Ratio
- STG $3.20
- GNTA N/A
- Revenue Growth
- STG N/A
- GNTA N/A
- 52 Week Low
- STG $4.25
- GNTA $2.74
- 52 Week High
- STG $15.00
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- STG 50.13
- GNTA 53.23
- Support Level
- STG $10.08
- GNTA $3.51
- Resistance Level
- STG $11.50
- GNTA $3.96
- Average True Range (ATR)
- STG 1.57
- GNTA 0.18
- MACD
- STG -0.28
- GNTA 0.01
- Stochastic Oscillator
- STG 0.85
- GNTA 68.59
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.